Table 2. Analysis of 19 Real-Life Initiative Studies Regarding the Extent to Which Each Study Entails the Elements Identified for RPM Integrated Care Implementation .
First Author, Year, Country | Target Population (and Study Design) | Individual & Environment | Service Delivery | Leadership & Governance | Workforce | Financing | Technologies & Medical Products | Information & Research | Monitoring | Applied Technologies | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(a) | (b) | (c) | (d) | (e) | (f) | (g) | (h) | (i) | (j) | (k) | (l) | (m) | (n) | (o) | (p) | (q) | (r) | |||
Agarwal et al, 2021, Canada47 | COVID-19 (Descriptive study) | ∘ | ∗ | ∗ | ∘ | ● | H2H | ● | ∗ | S | ∗ | ● | ∘ | B2B | ● | ∘ | ● | ● | ● | Telephone and/or VC + Messaging service + Patient portal (to collect e-PROs) + TM devices (ie, pulse oximeter, thermometer) + EMR + e-learning + Dashboard |
Black et al, 2014, USA29 | HF (RCT) | ∘ | ● | ● | ∘ | ∘ | H2H | ∗ | ∘ | S | ● | ∗ | ∗ | B2B | ∗ | ∗ | ● | ∘ | ● | Telephone + BT-enabled TM devices (ie, scale, BP monitor) + EMR |
Brooks et al, 2013, USA35 | PTSD (Program assessment) | ● | ● | ● | ∘ | ∗ | 2HT | ● | ● | A | ● | ● | ∘ | - | ∗ | ∘ | ∗ | ∘ | ∗ | VC + Patient portal (to collect e-PROs) + EMR + e-learning |
Casale et al, 2021, USA11 | COVID-19 (Program assessment) | ∘ | ∗ | ● | ∘ | ∗ | H2H | ● | ∗ | S | ● | ● | ∗ | B2B | ∗ | ∗ | ● | ∘ | ∘ | Telephone + TM devices (ie, pulse oximeter, BP monitor, thermometer) + EMR |
Cheville et al, 2018, USA37 | Cancer and hematologic conditions (RCT) | ∘ | ∗ | ∗ | ∗ | ∘ | 2HT | ● | ∗ | A | ● | ● | ∘ | - | ● | ∗ | ● | ∗ | ● | Telephone and/or VC + Patient portal (to collect e-PROs) + Telerehabilitation + Pedometer + EMR + e-learning |
Dontje et al, 2021, Netherlands44 | ALS (Participatory action study) | ● | ● | ● | ∘ | ∘ | H2H | ∗ | ∘ | S | ● | ∘ | ∘ | B2B | ∗ | ∗ | ∗ | ∗ | ● | Messaging service + Patient portal (ie, mobile app, to collect e-PROs) + Weighting scale + EMR |
Fairbrother et al, 2013, Scotland54 | HF (Qualitative study) | ∘ | ∘ | ∗ | ∘ | ∘ | H2H | ∘ | ∘ | S | ∗ | ∘ | ∘ | B2B | ∗ | ∘ | ● | ∘ | ∘ | Telephone + Patient portal (to collect e-PROs) + BT-enabled TM devices (ie, pulse oximeter, BP monitor, scale) + e-learning |
Foster et al, 2021, USA34 | Infants with SVP (Program assessment) | ∘ | ∗ | ● | ∗ | ∗ | H2H | ● | ∗ | S | ● | ∗ | ∗ | B2B | ● | ∘ | ● | ● | ● | VC + Patient portal (ie, mobile app, to collect e-PROs and for video/photo sharing) + TM devices (ie, scale and pulse oximeter) + EMR + e-learning + Dashboard |
Herkert et al, 2020, Netherlands45 | HF + COPD (Quasi-experimental study) | ● | ● | ● | ● | ● | H2H | ● | ∗ | S | ● | ∘ | ∘ | B2B | ● | ∘ | ● | ● | ● | Telephone and VC + Messaging service + Patient portal (to collect e-PROs) + BT-enabled TM devices (ie, BP monitor, pulse oximeter, scale, and thermometer) + EMR + Dashboard |
Krenitsky et al, 2020, USA14 | COVID-19 + prenatal care (Program assessment) | ∘ | ∘ | ∗ | ● | ∘ | H2H | ∘ | ∘ | S | ● | ∘ | ∘ | B2B | ● | ∗ | ● | ∘ | ∗ | VC + Patient portal (to collect e-PROs) + BT-enabled TM devices (ie, BP monitor, pulse oximeter, and thermometer) + EMR |
Pelletier et al, 2011, USA33 | Diabetes (Program assessment) | ∘ | ∗ | ∗ | ∘ | ∘ | H2H | ∗ | ∘ | S | ● | ∗ | ● | B2B | ∗ | ∘ | ∗ | ● | ∗ | Messaging service + Patient portal (for self-care enhancement) + TM devices (ie, glucometer and BP monitor) + Dashboard |
Realdon et al, 2018, Italy41 | Dementia (Program assessment) | ∘ | ∗ | ● | ∗ | ∗ | H2H | ∘ | ∘ | S | ● | ∘ | ∗ | B2B | ● | ● | ● | ● | ∘ | Messaging service + Patient portal (to collect e-PROs) + BT-enabled TM devices (ie, BP monitor, pulse oximeter, thermometer, scale, ECG, glucometer) + Smartwatch + Telerehabilitation + CRM + EMR–e-learning + Dashboard |
Ricci and Morichelli, 2013, Italy42 | Patients with CIED (Program assessment) | ∘ | ∗ | ● | ∘ | ∘ | 2HT | ● | ∗ | A | ● | ∘ | ∘ | B2C | ∗ | ∘ | ● | ∘ | ● | Telephone and e-mail + Patient portal (for data entry) + (Wireless) CIED |
Schenkel et al, 2020, USA38 | Lung transplant patients (Program assessment) | ∘ | ∗ | ● | ● | ∗ | 2HT | ● | ∗ | A | ● | ∘ | ∗ | B2C | ● | ∘ | ● | ∗ | ● | VC + Patient portal (to collect e-PROs) + BT-enabled TM devices (ie, BP monitor, pulse oximeter, scale, glucometer, spirometer) + EMR + e-learning |
Schmidt et al, 2018, Germany52 | Chronic cardio-vascular diseases (RCT) | ∘ | ∗ | ● | ∘ | ∗ | 2HT | ● | ∗ | A | ● | ∘ | ∘ | B2C | ● | ∗ | ∗ | ● | ● | Telephone + Patient portal (to collect e-PROs) + TM devices + EMR + e-learning + Dashboard |
Sheeran et al, 2011, USA32 | Depression (Feasibility study) | ∘ | ∗ | ● | ∘ | ∘ | H2H | ● | ∗ | S | ● | ∘ | ∘ | - | ∗ | ∘ | ∗ | ∘ | ● | Telephone + Patient portal (to collect e-PROs) + BT-enabled TM devices (ie, BP monitor, pulse oximeter, scale, ECG, glucometer) + e-learning |
Singh et al, 2011, USA31 | Post-acute care (Longitudinal case study) | ∗ | ● | ● | ∗ | ∗ | 2HT | ● | ● | A | ● | ∘ | ● | B2C | ∗ | ● | ● | ● | ● | Telephone + TM devices (ie, BP monitor, pulse oximeter, thermometer, scale, ECG, spirometer) + EMR + Dashboard |
Smaradottir et al, 2017, Norway53 | COPD (Program assessment) | ∘ | ● | ● | ∘ | ∘ | 2HT | ∗ | ∘ | A | ∗ | ∘ | ● | B2C | ∗ | ∗ | ∗ | ● | ∗ | Patient portal (to collect e-PROs) + Pulse oximeter + Dashboard |
Vuorinen et al, 2014, Finland51 | HF (RCT) | ∘ | ∗ | ● | ∘ | ∗ | H2H | ∗ | ∗ | S | ● | ∘ | ∘ | B2B | ● | ∗ | ● | ∘ | ● | Telephone + Patient portal (ie, mobile app, to collect e-PROs) + TM devices (ie, BP monitor, scale) + EMR |
Abbreviations: RPM, Remote patient monitoring; H2H, hospital-to-home; TM, telemonitoring; VC, videoconferencing; EMR, electronic medical record; B2B, business-to-business; BT, Bluetooth; BP, blood pressure; HF, heart failure; RCT, randomized controlled trial; PTSD, post-traumatic stress disorder; 2HT, high-touch-high-tech; e-PROs, electronic patient reported outcomes; SVP, single ventricle physiology; ALS, amyotrophic lateral sclerosis; CIED, cardiac implantable electronic devices; COPD, chronic obstructive pulmonary disease; B2C, business-to-consumer; CRM, customer relationship management tool.
Notes: ● Fully complying with Table 1; ∗ Partially complying with Table 1; ∘ Not complying with Table 1; A: actors’ coordination; S: stages’ coordination; (a) collaborative design process; (b) patient-centred implementation; (c) patient education and self-monitoring promotion; (d) multi-morbidity care; (e) dynamic trajectory of illness; (f) H2H vs 2HT; (g) coordination pivot; (h) shared decision-making culture; (i) stages vs actors’ coordination; (j) multidisciplinary core workforce; (k) supporting workforce; (l) coverage and/or reimbursement model; (m) B2B vs B2C; (n) ICTs and TM devices; (o) health data centre; (p) health indicators measurement; (q) clinical dashboards; (r) outcome measurements.